ROBIN ATWOOD: Open Payments
NPI 1679093876 · LIBERTY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 15 payments from 9 companies in 2025. Trend: 2023 $284 · 2024 $113 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 4 | $140 |
| ABBVIE INC. | 2 | $40 |
| Amgen Inc. | 2 | $30 |
| Novo Nordisk Inc | 1 | $18 |
| Abbott Laboratories | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Cipher Pharmaceuticals US LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 2 | $10 |
Products named: SUBLOCADE, EVENITY, QULIPTA, Ozempic, CARDIOMEMS, TRELEGY ELLIPTA, Natroba, MOUNJARO.
Industry payments across KY — which companies pay providers there.
